(19)
(11) EP 4 740 022 A1

(12)

(43) Date of publication:
13.05.2026 Bulletin 2026/20

(21) Application number: 24745894.6

(22) Date of filing: 04.07.2024
(51) International Patent Classification (IPC): 
G01N 33/68(2006.01)
G01N 33/92(2006.01)
(52) Cooperative Patent Classification (CPC):
G01N 33/92; G01N 33/6896; G01N 2800/085; G01N 2333/775
(86) International application number:
PCT/EP2024/068883
(87) International publication number:
WO 2025/008466 (09.01.2025 Gazette 2025/02)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 06.07.2023 DE 102023117862

(71) Applicant: Numares AG
93053 Regensburg (DE)

(72) Inventors:
  • DE JEL, Sebastian
    86739 Ederheim (DE)
  • STÄMMLER, Frank
    93051 Regensburg (DE)
  • RÖTZER, Sebastian
    93161 Sinzing (DE)
  • ROBERTSON, Andrew
    80798 München (DE)
  • EIGLSPERGER, Johannes
    84069 Schierling-Walkenstetten (DE)

(74) Representative: Maikowski & Ninnemann Patentanwälte Partnerschaft mbB 
Postfach 15 09 20
10671 Berlin
10671 Berlin (DE)

   


(54) USE OF A BIOMARKER FOR DETERMINING THE RISK OF AN INDIVIDUAL TO HAVE HEPATIC ENCEPHALOPATHY